Abstract
A 36-year-old woman was seen in the multidisciplinary breast cancer clinic of this hospital for management of hormone-receptor–positive breast cancer. She had a 1.4-cm, grade 2 of 3, infiltrating ductal carcinoma that was positive for estrogen-receptor protein and progesterone-receptor protein and negative for human epidermal growth factor receptor type 2, with micrometastases to 1 of 13 axillary lymph nodes detected by immunohistochemical analysis. A management decision was made.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
